Sign in

CIK 0001681087

  • Non-accelerated filer
  • Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
810710585
Phone
+1 339-666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake
Date Insider Transaction Shares Price Value Owned after
2019-04-05 MACKAY GEOFFREY Sale −13,302 $27.26 $363K 410,221
2019-03-05 MACKAY GEOFFREY Grant or award · Stock Option (Right to Buy) +100,000 100,000
2019-01-16 SVLSF VI, LLC 10% owner Other disposition −778,663 1,866,791
2019-01-16 SVLSF VI, LLC 10% owner Other disposition −26,660 63,913
2019-01-07 Vickers Philip J. Director Grant or award · Stock Option (Right to Buy) +18,743 18,743
2019-01-02 Avruch Steven VP & General Counsel Grant or award · Stock Option (Right to Buy) +88,636 88,636
2019-01-02 Ostrowski Erik Chief Financial Officer Grant or award +2,300 2,300
2019-01-02 Ostrowski Erik Chief Financial Officer Grant or award · Stock Option (Right to Buy) +186,000 186,000
2018-12-17 Volck Birgitte President of R&D Grant or award · Stock Option (Right to Buy) +293,000 293,000
2018-10-08 Dorton Katina Chief Financial Officer Exercise or conversion +10,000 $0.91 $9K 10,000
2018-10-08 Dorton Katina Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 148,318
2018-10-08 KREHER NERISSA Chief Medical Officer Exercise or conversion +2,942 $0.91 $3K 2,942
2018-10-08 KREHER NERISSA Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −2,942 24,629
2018-06-25 Atlas Venture Fund X, L.P. 10% owner Conversion +806,711 806,711
2018-06-25 Atlas Venture Fund X, L.P. 10% owner Conversion +3,044,579 3,851,290
2018-06-25 Atlas Venture Fund X, L.P. 10% owner Conversion +905,188 4,756,478
2018-06-25 Atlas Venture Fund X, L.P. 10% owner Conversion · Series Seed Preferred Stock −3,333,333 0
2018-06-25 Atlas Venture Fund X, L.P. 10% owner Conversion · Series A Preferred Stock −12,580,199 0
2018-06-25 Atlas Venture Fund X, L.P. 10% owner Conversion · Series B Preferred Stock −3,740,239 0
2018-06-25 Requadt Scott Director Conversion +2,283,434 2,283,434

Page 15 of 17 · 322 trades